Financial statements Endorfina Malbork
Balance sheet of Endorfina Malbork
Company age:
Age:
4 y. 13 d.
Balance sheet data of ENDORFINA MALBORK
|
Year
|
2021
|
2022
|
2023
|
|---|---|---|---|
| Total assets | 2 100,00 | 85 201,34 | 144 557,86 |
| A. Fixed assets | 0,00 | 45 401,34 | 35 165,34 |
| B. Current assets | 2 100,00 | 39 800,00 | 109 392,52 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | - | - | - |
| Total liabilities | 2 100,00 | 85 201,34 | 144 557,86 |
| A. Equity | 2 100,00 | 39 114,43 | 64 809,88 |
| B. Liabilities and provisions for liabilities | 0,00 | 46 086,91 | 79 747,98 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 0,00 | 3 999,11 | 47 186,02 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.